| | row_id,series_id,inoculum_rank,organism,strain_id,antibiotic_name,antibiotic_class,exposure_index,mic_mg_L,cfu0_log10,cfu24_log10,kill_24_log10,media,assay_method,source_type,inoculum_effect_signal,earliest_inoculum_effect,notes |
| | ABXPD009-TR-0001,S1,1,Escherichia coli,EC-ATCC25922,meropenem,carbapenem,1.00,0.03,6.0,3.0,3.0,CAMHB,inoculum_time_kill,simulated,0,0,baseline inoculum |
| | ABXPD009-TR-0002,S1,2,Escherichia coli,EC-ATCC25922,meropenem,carbapenem,1.00,0.03,7.0,4.4,2.6,CAMHB,inoculum_time_kill,simulated,0,0,small loss expected |
| | ABXPD009-TR-0003,S1,3,Escherichia coli,EC-ATCC25922,meropenem,carbapenem,1.00,0.03,8.0,6.0,2.0,CAMHB,inoculum_time_kill,simulated,0,0,still proportional |
| | ABXPD009-TR-0004,S2,1,Klebsiella pneumoniae,KP-CLIN250,ceftriaxone,beta_lactam,1.00,0.50,6.2,4.0,2.2,CAMHB,inoculum_time_kill,simulated,0,0,baseline inoculum |
| | ABXPD009-TR-0005,S2,2,Klebsiella pneumoniae,KP-CLIN250,ceftriaxone,beta_lactam,1.00,0.50,7.2,6.0,1.2,CAMHB,inoculum_time_kill,simulated,1,1,disproportionate loss begins |
| | ABXPD009-TR-0006,S2,3,Klebsiella pneumoniae,KP-CLIN250,ceftriaxone,beta_lactam,1.00,0.50,8.2,7.6,0.6,CAMHB,inoculum_time_kill,simulated,1,0,collapse continues |
| | ABXPD009-TR-0007,S3,1,Staphylococcus aureus,SA-ATCC29213,vancomycin,glycopeptide,1.00,1.00,6.0,4.6,1.4,CAMHB,inoculum_time_kill,simulated,0,0,baseline inoculum |
| | ABXPD009-TR-0008,S3,2,Staphylococcus aureus,SA-ATCC29213,vancomycin,glycopeptide,1.00,1.00,7.0,5.8,1.2,CAMHB,inoculum_time_kill,simulated,0,0,small change |
| | ABXPD009-TR-0009,S3,3,Staphylococcus aureus,SA-ATCC29213,vancomycin,glycopeptide,1.00,1.00,8.0,7.0,1.0,CAMHB,inoculum_time_kill,simulated,0,0,still proportional |
| | ABXPD009-TR-0010,S4,1,Pseudomonas aeruginosa,PA-CLIN610,ciprofloxacin,fluoroquinolone,1.00,0.50,7.0,6.4,0.6,CAMHB,inoculum_time_kill,simulated,0,0,single row control |
| |
|
